Konstantinos Syrigos
- Effectiveness of mesothelin family proteins and osteopontin for malignant mesotheliomaBy Ioannis Pantazopoulos, Paraskevi Boura, Theodoros Xanthos and Konstantinos SyrigosIoannis Pantazopoulos*12th Dept of Respiratory Medicine, Sotiria General HospitalParaskevi Boura#Oncology Unit, 3rd Dept of Medicine, School of Medicine, University of Athens, Sotiria General HospitalTheodoros Xanthos¶MSc Programme “Cardiopulmonary Resuscitation”, University of Athens, Medical School, Athens, GreeceKonstantinos Syrigos#Oncology Unit, 3rd Dept of Medicine, School of Medicine, University of Athens, Sotiria General Hospital
- Mesothelin and osteopontinBy Ioannis Pantazopoulos, Theodoros Xanthos, Paraskevi Boura and Konstantinos SyrigosIoannis Pantazopoulos112th Dept of Respiratory Medicine, Sotiria General Hospital, AthensTheodoros Xanthos2MSc Programme “Cardiopulmonary Resuscitation”, University of Athens, Medical School, AthensParaskevi Boura3Oncology Unit, 3rd Dept of Medicine, School of Medicine, University of Athens, Sotiria General Hospital, Athens, GreeceKonstantinos Syrigos3Oncology Unit, 3rd Dept of Medicine, School of Medicine, University of Athens, Sotiria General Hospital, Athens, Greece
- Antibiotic prophylaxis in chemotherapy-induced neutropenia in lung cancer patientsBy Vasileios Kouranos, Antonios Vassias, George Dimopoulos and Konstantinos SyrigosVasileios Kouranos18th Pulmonary Clinic, General Hospital of Chest Diseases “Sotiria”, Athens, GreeceAntonios Vassias23rd Oncology Unit, General Hospital of Chest Diseases “Sotiria”, University of Athens, Athens, GreeceGeorge Dimopoulos32nd Department of Critical Care, Attiko University Hospital, Athens, GreeceKonstantinos Syrigos23rd Oncology Unit, General Hospital of Chest Diseases “Sotiria”, University of Athens, Athens, Greece
- The impact of neuroendocrine differentiation in the prognosis of non-small cell lung cancerBy Andriani Charpidou, Christina Fevranoglou, Tsimpoukis Sotirios, Boura Paraskevi, Marios Zontanos, Ioannis Danos and Konstantinos SyrigosAndriani Charpidou1Oncology Unit, 3rd Dept of Medicine, University of Athens Medical School, Athens, GreeceChristina Fevranoglou1Oncology Unit, 3rd Dept of Medicine, University of Athens Medical School, Athens, GreeceTsimpoukis Sotirios1Oncology Unit, 3rd Dept of Medicine, University of Athens Medical School, Athens, GreeceBoura Paraskevi1Oncology Unit, 3rd Dept of Medicine, University of Athens Medical School, Athens, GreeceMarios Zontanos1Oncology Unit, 3rd Dept of Medicine, University of Athens Medical School, Athens, GreeceIoannis Danos210th Pulmonary Department, "Sotiria" Hospital of Chest Diseases, Athens, GreeceKonstantinos Syrigos1Oncology Unit, 3rd Dept of Medicine, University of Athens Medical School, Athens, Greece
- Docetaxel-related peripheral neuropathy is a dose-dependent event; a retrospective study in a Greek population with NSCLCBy Alexandros Kavvadias, Ioannis Gkiozos, Panagiotis Boulas, Georgios Tsoukalas and Konstantinos SyrigosAlexandros Kavvadias14th Respiratory Department, General and Chest Diseases Hospital "Sotiria", Athens, GreeceIoannis Gkiozos2Oncology Unit, 3rd Internal Medicine Department, General and Chest Diseases Hospital "Sotiria", Athens, GreecePanagiotis Boulas14th Respiratory Department, General and Chest Diseases Hospital "Sotiria", Athens, GreeceGeorgios Tsoukalas14th Respiratory Department, General and Chest Diseases Hospital "Sotiria", Athens, GreeceKonstantinos Syrigos2Oncology Unit, 3rd Internal Medicine Department, General and Chest Diseases Hospital "Sotiria", Athens, Greece
- Thymic tumours: Diagnostic and therapeutic approachBy Sotirios Moraitis, Konstantinos Kanakakis, Panagiotis Hountis, Ioannis Gkiozos, Andriani Charpidou and Konstantinos SyrigosSotirios Moraitis1Thoracic Surgery Department, Naval and Veterans Hospital of Athens, Athens, GreeceKonstantinos Kanakakis1Thoracic Surgery Department, Naval and Veterans Hospital of Athens, Athens, GreecePanagiotis Hountis1Thoracic Surgery Department, Naval and Veterans Hospital of Athens, Athens, GreeceIoannis Gkiozos2Oncology Unit, 3rd Dept. of Internal Medicine, University of Athens Medical School, “Sotiria” General and Chest Diseases Hospital, Athens, GreeceAndriani Charpidou2Oncology Unit, 3rd Dept. of Internal Medicine, University of Athens Medical School, “Sotiria” General and Chest Diseases Hospital, Athens, GreeceKonstantinos Syrigos2Oncology Unit, 3rd Dept. of Internal Medicine, University of Athens Medical School, “Sotiria” General and Chest Diseases Hospital, Athens, Greece
- Evaluation of outpatient infections in lung cancer patients treated with chemotherapy and/or radiotherapyBy Vasileios Kouranos, Emily Tsaroucha, Antonis Vassias, John Arapis, John Gkiozos and Konstantinos SyrigosVasileios Kouranos18th Pulmonary Clinic, General Hospital of Chest Diseases "Sotiria", Athens, GreeceEmily Tsaroucha18th Pulmonary Clinic, General Hospital of Chest Diseases "Sotiria", Athens, GreeceAntonis Vassias23rd Oncology Unit, University of Athens, GreeceJohn Arapis18th Pulmonary Clinic, General Hospital of Chest Diseases "Sotiria", Athens, GreeceJohn Gkiozos23rd Oncology Unit, University of Athens, GreeceKonstantinos Syrigos23rd Oncology Unit, University of Athens, Greece
- Bevacizumab (Bv) in elderly pts with NSCLC: Experience at a tertiary referral centerBy Dimitris Vassos, Sofia Tsagouli, Marios Zontanos, Antonis Vassias, Sotiris Tsimpoukis, Paraskevi Boura, Andrianni Charpidou and Konstantinos SyrigosDimitris Vassos1Oncology Unit GPP, Sotiria General Hospital, Athens, GreeceSofia Tsagouli1Oncology Unit GPP, Sotiria General Hospital, Athens, GreeceMarios Zontanos1Oncology Unit GPP, Sotiria General Hospital, Athens, GreeceAntonis Vassias1Oncology Unit GPP, Sotiria General Hospital, Athens, GreeceSotiris Tsimpoukis1Oncology Unit GPP, Sotiria General Hospital, Athens, GreeceParaskevi Boura1Oncology Unit GPP, Sotiria General Hospital, Athens, GreeceAndrianni Charpidou1Oncology Unit GPP, Sotiria General Hospital, Athens, GreeceKonstantinos Syrigos1Oncology Unit GPP, Sotiria General Hospital, Athens, Greece
- Erlotinib (E) in elderly pts with NSCL: Experience at a tertiary referral centerBy Alexios Strimpakos, Dimitris Vassos, Antonis Vassias, Sotiris Tsimboukis, Paraskevi Boura, Sofia Tsagkouli, Marios Zontanos and Konstantinos SyrigosAlexios Strimpakos1Oncology Unit GPP, Sotiria General Hospital, Athens, GreeceDimitris Vassos1Oncology Unit GPP, Sotiria General Hospital, Athens, GreeceAntonis Vassias1Oncology Unit GPP, Sotiria General Hospital, Athens, GreeceSotiris Tsimboukis1Oncology Unit GPP, Sotiria General Hospital, Athens, GreeceParaskevi Boura1Oncology Unit GPP, Sotiria General Hospital, Athens, GreeceSofia Tsagkouli1Oncology Unit GPP, Sotiria General Hospital, Athens, GreeceMarios Zontanos1Oncology Unit GPP, Sotiria General Hospital, Athens, GreeceKonstantinos Syrigos1Oncology Unit GPP, Sotiria General Hospital, Athens, Greece
- Afatinib (A) vs erlotinib (E) as second-line treatment of patients (pts) with advanced squamous cell carcinoma (SCC) of the lung: LUX-Lung 8 (LL8), a phase III trialBy Shirish Gadgeel, Jean-Charles Soria, Enriqueta Felip, Manuel Cobo, Shun Lu, Konstantinos Syrigos, Ki Hyeong Lee, Erdem Göker, Vassileios Georgoulias, Wei Li, Dolores Isla, Salih Zeki Guclu, Alessandro Morabito, Young Joo Min, Andreas Ardizzoni, Bushi Wang, Vikram Chand, Glenwood Goss and For the LUX-Lung 8 InvestigatorsShirish Gadgeel1Department of Oncology, Karmanos Cancer Center, Detroit, MI United StatesJean-Charles Soria2Drug Development Department, Gustave Roussy Cancer Campus and University Paris-Sud, Paris, FranceEnriqueta Felip3Department of Oncology, Vall d'Hebron University Hospital, Barcelona, SpainManuel Cobo4Department of Oncology, Hospital Carlos Haya, Malaga, SpainShun Lu5Shanghai Lung Tumor Clinical Medical Center, Shanghai Chest Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, ChinaKonstantinos Syrigos63rd Department of Medicine, Athens School of Medicine, Athens, GreeceKi Hyeong Lee7College of Medicine, Chungbuk National University, Cheongju, KoreaErdem Göker8Faculty of Medicine, Ege University, Izmir, TurkeyVassileios Georgoulias9Department of Medical Oncology, University Hospital of Heraklion, Heraklion, Crete GreeceWei Li10Department of Hematology & Oncology, First Hospital Affiliated to Jilin University, Jilin, ChinaDolores Isla11Department of Medical Oncology, Hospital Lozano Blesa, Zaragoza, SpainSalih Zeki Guclu12Chest Diseases Clinic, Izmir Chest Diseases Research Hospital, Izmir, TurkeyAlessandro Morabito13Thoraco-Pulmonary Department, Istituto Nazionale Tumori "Fondazione G.Pascale"- IRCCS, Naples, ItalyYoung Joo Min14Department of Medicine, Ulsan University Hospital, Ulsan, KoreaAndreas Ardizzoni15Department of Medical Oncology, University Hospital, Parma, ItalyBushi Wang16Statistics, Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT United StatesVikram Chand17Clinical Oncology, Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT United StatesGlenwood Goss18Division of Medical Oncology, University of Ottawa, Ottawa, Canada1Department of Oncology, Karmanos Cancer Center, Detroit, MI United States
Buying books on this site
Purchases made on this website are of electronic books only.
About the ERS books
The ERS Monograph is the quarterly book series from the European Respiratory Society. Each Monograph covers a specific area of respiratory medicine, providing in-depth reviews that give clinicians at all levels a concise, comprehensive guide to symptoms, diagnosis and treatment.
The ERS Handbooks are compact guides to broad areas of the respiratory field. Launched in 2010, the series now covers adult, paediatric and sleep respiratory medicine, includes a companion volume of self-assessment questions and features the ERS Practical Handbooks.